Pankaj Malhotra to Biomarkers
This is a "connection" page, showing publications Pankaj Malhotra has written about Biomarkers.
Connection Strength
0.258
-
Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J. 2022 Feb; 98(1156):87-90.
Score: 0.165
-
COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2022 Feb; 98(1156):91-97.
Score: 0.041
-
Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre. Indian J Med Microbiol. 2018 Oct-Dec; 36(4):557-563.
Score: 0.036
-
Evaluation of Bortezomib-Induced Neuropathy Using Total Neuropathy Score (Reduced and Clinical Versions) and NCI CTCAE v4.0 in Newly Diagnosed Patients With Multiple Myeloma Receiving Bortezomib-Based Induction. Clin Lymphoma Myeloma Leuk. 2017 08; 17(8):513-519.e1.
Score: 0.008
-
Natriuretic peptides in the evaluation and management of degenerative mitral regurgitation: a systematic review. Heart. 2017 05; 103(10):738-744.
Score: 0.008